-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
RB Loss in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to Small Cell Lung Cancer
Study
EGAS00001001102
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Study
EGAS00001007029
-
CALGB/SWOG 80405: Genome-Wide Association Study of Patients with Advanced or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy Combined with Cetuximab and/or Bevacizumab
Study
phs003428
-
Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell Progeny
Study
phs003898
-
Single cell atlas of relapsed/refractory large B-cell lymphoma
Study
EGAS50000001293
-
Excised DNA Circles from V(D)J Recombination Promote Relapsed Leukaemia
Study
EGAS50000000407
-
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study
Study
EGAS50000001243
-
EXPRESSION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BREAST CANCER METASTASES AND NORMAL TISSUE
Study
EGAS50000001334